19202-36-9

Basic information

• Product Name: HINOKIFLAVONE
• Synonyms: HINOKIFLAVONE;4',6''-BIAPIGENIN;4',6''-O-BIAPIGENIN;6-[4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone;2-(4-Hydroxyphenyl)-5,7-dihydroxy-6-[4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-4H-1-benzopyran-4-one;4''',5,5'',7,7''-Pentahydroxy(4',6''-oxybisflavone);4',5,7-Trihydroxy-6-[4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]flavone;6-[4-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
• CAS NO: 19202-36-9
• Molecular Formula: C₃₀H₁₈O₁₀
• Molecular Weight: 538.46
• EINECS: 242-877-4
• Product Categories: Flavones
• Mol File: 19202-36-9.mol
• Article Data: 0

Chemical Properties

• Melting Point: 353-355°C
• Boiling Point: 841.5 °C at 760 mmHg
• Flash Point: 284.8 °C
• Appearance: /
• Density: 1.622
• Vapor Pressure: 1.22E-29mmHg at 25°C
• Refractive Index: 1.77
• Storage Temp.: 2-8°C
• PKA: 5.70±0.40(Predicted)
• CAS DataBase Reference: HINOKIFLAVONE(CAS DataBase Reference)
• NIST Chemistry Reference: HINOKIFLAVONE(19202-36-9)
• EPA Substance Registry System: HINOKIFLAVONE(19202-36-9)

Safety Data

• Hazardous Substances Data: 19202-36-9(Hazardous Substances Data)

Usage

Definition

ChEBI: A biflavonoid that is apigenin substituted by a 4-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)phenoxy group at position 6. A diflavonyl ether, it is isolated from Rhus succedanea and has been found to possess significant cytotoxic otential.

InChI:InChI=1/C30H18O10/c31-16-5-1-14(2-6-16)24-12-21(35)28-26(40-24)13-22(36)30(29(28)37)38-18-7-3-15(4-8-18)23-11-20(34)27-19(33)9-17(32)10-25(27)39-23/h1-13,31-33,36-37H

Downstream Products

• 1027007-26-6 C₅₀H₄₅NO₂₂ 
• 19825-55-9 penta-O-acetylhinokiflavone 

Related news

13C NMR studies of some naturally occurring amentoflavone and HINOKIFLAVONE (cas 19202-36-9) biflavonoids08/01/2019

The 13C NMR spectra of a range of amentoflavone and hinokiflavone biflavonoids are reported, most for the first time. Substituent shifts relating to the interflavonoid linkages and to specific methylation patterns are defined and appear to be of diagnostic value.detailed

Evaluation of the hepatoprotective effect of combination between HINOKIFLAVONE (cas 19202-36-9) and Glycyrrhizin against CCl4 induced toxicity in rats07/31/2019

Liver diseases are one of the fatal syndromes due to the vital role of the liver. Most of the effective treatment of liver conditions are of natural origin. Silymarin (SI) is the standard drug used for treatment of impaired liver functions. Two natural compounds possessing promising liver protec...detailed

HINOKIFLAVONE (cas 19202-36-9) induces apoptosis in melanoma cells through the ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion07/30/2019

Melanoma, the highest degree of malignancy, is one of the most common skin tumors. However, there is no effective strategy to treat melanoma in current clinical practice. Therefore, it is urgent to find an efficient drug to overcome melanoma. Here, the in vitro anticancer effects of a natural pr...detailed

UHPLC-Q-TOF-MS/MS method based on four-step strategy for metabolites of HINOKIFLAVONE (cas 19202-36-9) in vivo and in vitro07/29/2019

Hinokiflavone (HF), belonging to biflavonoids, possesses excellent pharmacological activities, including anti-inflammatory, antioxidant and antitumor activity. Nevertheless, its metabolism in vivo (rats) and in vitro (rat liver microsomes and intestinal flora) is presently not characterized. In ...detailed